Effective measures for the<unk>  prevention  of tricuspid atresia as prenatal screening include fetal sonography between 10-14 weeks of pregnancy for measurement of nuchal translucency thickness, fetal echocardiography between 18-22 weeks of pregnancy
Tricuspid atresia primary prevention
Tricuspid atresia secondary prevention
Endocardial cushion defect secondary prevention
Tricuspid atresia medical therapy
Total anomalous pulmonary venous connection medical therapy
Patent ductus arteriosus medical therapy in preterm infants
Tricuspid stenosis primary prevention
Atrial septal defect percutaneous closure complications